A Case Series of HCV Genotype 1a Infection Patients With HIV Co-infection Treated With 8 Weeks of Ledipasvir-Sofosbuvir

被引：0
|
作者：
Umar, Shifa [1 ]
Hsiao, Chiu-Bin [1 ]
机构：
[1] Allegheny Hlth Network, Pittsburgh, PA USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2017年 / 112卷
关键词：
D O I：
10.14309/00000434-201710001-02128
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
2127
引用
收藏
页码：S1179 / S1179
页数：1
相关论文
共 50 条
  • [21] Sustained Virologic Suppression After 4 Weeks of Ledipasvir/Sofosbuvir in Human Immunodeficiency Virus (HIV)/Hepatitis C Virus (HCV) Co-Infection
    Havens, Joshua P.
    Regan, Nichole N.
    Bares, Sara H.
    AMERICAN JOURNAL OF CASE REPORTS, 2020, 21
  • [22] Ledipasvir and Sofosbuvir for Previously Treated HCV Genotype 1 Infection (vol 370, pg 1483, 2014)
    Afdhal, N.
    NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (06): : 584 - 584
  • [23] NO DIFFERENCE IN SUSTAINED VIROLOGIC RESPONSE IN BLACK PATIENTS WITH GENOTYPE 1 CHRONIC HEPATITIS C INFECTION TREATED WITH 8 WEEKS VERSUS 12 WEEKS OF LEDIPASVIR/SOFOSBUVIR
    Cioffi, Joseph
    Siegel, Marc
    HEPATOLOGY, 2019, 70 : 968A - 968A
  • [24] Ledipasvir-sofosbuvir for treating Japanese patients with chronic hepatitis C virus genotype 2 infection
    Asahina, Yasuhiro
    Itoh, Yoshito
    Ueno, Yoshiyuki
    Matsuzaki, Yasushi
    Takikawa, Yasuhiro
    Yatsuhashi, Hiroshi
    Genda, Takuya
    Ikeda, Fusao
    Matsuda, Takuma
    Dvory-Sobol, Hadas
    Jiang, Deyuan
    Massetto, Benedetta
    Osinusi, Anu O.
    Brainard, Diana M.
    McHutchison, John G.
    Kawada, Norifumi
    Enomoto, Nobuyuki
    LIVER INTERNATIONAL, 2018, 38 (09) : 1552 - 1561
  • [25] Ledipasvir Plus Sofosbuvir for 12 Weeks in Patients With Hepatitis C Genotype 4 Infection
    Abergel, Armand
    Metivier, Sophie
    Samuel, Didier
    Jiang, Deyuan
    Kersey, Kathryn
    Pang, Phillip S.
    Svarovskaia, Evguenia
    Knox, Steven J.
    Loustaud-Ratti, Veronique
    Asselah, Tarik
    HEPATOLOGY, 2016, 64 (04) : 1049 - 1056
  • [26] Efficacy of Ledipasvir Plus Sofosbuvir for 8 or 12 Weeks in Patients With Hepatitis C Virus Genotype 2 Infection
    Gane, Edward J.
    Hyland, Robert H.
    Yang, Yin
    Svarovskaia, Evguenia
    Stamm, Luisa M.
    Brainard, Diana M.
    McHutchison, John G.
    Stedman, Catherine A. M.
    GASTROENTEROLOGY, 2017, 152 (06) : 1366 - 1371
  • [27] Efficacy and Tolerability of Daclatasvir/Sofosbuvir (Datex) in Patients with HIV-HCV Co-infection
    Shokatpour, Narjes
    Sali, Shahnaz
    Daneshpazhouh, Batool
    Mardani, Masoud
    ARCHIVES OF CLINICAL INFECTIOUS DISEASES, 2020, 15 (03): : 1 - 7
  • [28] Treatment With Ledipasvir-Sofosbuvir for 12 or 24 Weeks in Kidney Transplant Recipients With Chronic Hepatitis C Virus Genotype 1 or 4 Infection
    Colombo, Massimo
    Aghemo, Alessio
    Liu, Hong
    Zhang, Jie
    Dvory-Sobol, Hadas
    Hyland, Robert
    Yun, Chohee
    Massetto, Benedetta
    Brainard, Diana M.
    McHutchison, John G.
    Bourliere, Marc
    Peck-Radosavljevic, Markus
    Manns, Michael
    Pol, Stanislas
    ANNALS OF INTERNAL MEDICINE, 2017, 166 (02) : 109 - +
  • [29] Eight Weeks of Ledipasvir/Sofosbuvir Is Effective for Selected Patients With Genotype 1 Hepatitis C Virus Infection
    Kowdley, Kris V.
    Sundaram, Vinay
    Jeon, Christie Y.
    Qureshi, Kamran
    Latt, Nyan L.
    Sahota, Amandeep
    Lott, Stephen
    Curry, Michael P.
    Tsai, Naoky
    Chaiyakunapruk, Nathorn
    Lee, Yoori
    Petersen, Jorg
    Buggisch, Peter
    HEPATOLOGY, 2017, 65 (04) : 1094 - 1103
  • [30] Treatment of Patients with Hepatitis C Virus infection (Genotype 4) with Ledipasvir-Sofosbuvir in the liver transplant setting
    Abaalkhail, Faisal A.
    Elsiesy, Hussein A.
    Al Sebayel, Mohammed
    Aljedai, Ahmed
    Ajlan, Aziza A.
    Elbeshbeshy, Hany
    Al-Hamoudi, Waleed K.
    HEPATOLOGY, 2016, 64 : 956A - 957A
12345